Fingerprint Dive into the research topics of '4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo
Samir Mehndiratta, Ruei Shian Wang, Han Li Huang, Chih Jou Su, Chia Ming Hsu, Yi Wen Wu, Shiow Lin Pan, Jing Ping Liou
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- Department of Pharmacology
- Department of Pharmaceutical Sciences
- Ph.D. Program in Drug Discovery and Development Industry
- School of Pharmacy
- TMU Research Center of Cancer Translational Medicine
- TMU Biomedical Commercialization Center
- Research Center of Thoracic Medicine
- Master Program in Clinical Pharmacogenomics and Pharmacoproteomics
Research output: Contribution to journal › Article › peer-review
12
Citations
(Scopus)